Posted on 6/2/20
Why Pfizer's Shares Are Slipping 7.6% Today
What happened Shares are tumbling after Pfizer (NYSE:PFE) reported that its breast cancer drug, Ibrance, came up shy in a phase 3 trial evaluating its use . . .
Posted on 6/1/20
Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Intellia Therapeutics, Inc. (NASDAQ: NTLA) announced an expansion of their existing collaboration to provide Regeneron with rights to develop products . . .
Posted on 6/1/20
TapestryHealth Is The New Name Of Tapestry Telehealth
"You cannot meet the needs of the skilled nursing industry today if you are a traditional telemedicine provider," said Dr. David Chess, founder and CEO of . . .
Posted on 6/1/20
Pfizer Comes Up Empty In Ibrance Breast Cancer Study
Pfizer (NYSE:PFE) announces that, based on a futility analysis by the independent Data Monitoring Committee, a Phase 3 clinical trial, PALLAS, evaluating Ibrance (palbociclib) and adjuvant . . .
Posted on 6/1/20
Pfizer: Set Limit Orders No Higher Than $33.94
SummaryThe Upjohn split-off will be happening at some point in the second half of 2020, unhampered by COVID-19.Generics businesses command high margins, so even at lower . . .
Posted on 6/1/20
Merck's Keytruda Better Than Chemotherapy for Certain Colon Cancers
Chalk up another win for Merck's (NYSE:MRK) blockbuster cancer drug Keytruda, this time in patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) unresectable or . . .
Posted on 6/1/20
Is Pfizer a Great Dividend Stock?
Facing economic uncertainties or prolonged downturns, investors typically seek the safe haven of defensive stocks. Large multinational pharmaceutical companies fall into this category. Illness does not . . .
Posted on 6/1/20
Pfizer Breast Cancer Drug Posts "Disappointing" Results in Clinical Trials
One of Pfizer's (NYSE:PFE) blockbuster drugs has effectively flopped in a late-stage combination therapy trial. The company announced on Friday that the results of a Phase . . .
Posted on 6/1/20
Regeneron Completes Offering Of Sanofi-Held Stock
Regeneron Pharmaceuticals (NASDAQ:REGN) has finalized its secondary offering of ~13M common shares held by collaboration partner Sanofi (NASDAQ:SNY), including the full exercise of underwriters' option to . . .
Posted on 6/1/20
Caladrius Biosciences Closes $4.3M Registered Direct Offering
BASKING RIDGE, N.J., (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not . . .
Posted on 6/1/20
Fortress Biotech Prices Series A Preferred Stock Offering
NEW YORK, (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Common Stock: Nasdaq: FBIO) (Preferred Stock: Nasdaq: FBIOP), an innovative biopharmaceutical company, today announced that it has priced . . .
Posted on 6/1/20
Regeneron Completes Secondary Offering of Common Stock
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has completed the secondary offering of 13,014,646 shares of its common stock held by Sanofi, which includes . . .
Posted on 5/29/20
Akari Therapeutics Reports First Quarter 2020 Financial Results and Highlights Recent Clinical Progress
NEW YORK and LONDON, May 29, 2020 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune . . .
Posted on 5/29/20
Novartis to Manufacture Mass General's Coronavirus Vaccine Candidate
Another one of the world's largest pharmaceutical companies is throwing its weight behind the development of a coronavirus vaccine. Novartis (NYSE:NVS) will partner with Massachusetts General . . .
Posted on 5/29/20
Is Johnson and Johnson Stock a Buy?
Johnson & Johnson (NYSE:JNJ) is a big name in the healthcare industry that has produced stable and consistent returns for investors over the years. It also . . .
Posted on 5/29/20
3 Reasons Why Biohaven Pharmaceuticals' Stock Is Taking Off
Shares of Biohaven Pharmaceutical (NYSE:BHVN) have nearly doubled since mid-March, including a jump of more than 11% since May 21, with the stock closing at $58.38 . . .
Posted on 5/29/20
Dr. Meghan Patel Joins Capital Health OB/GYN
Dr. Meghan Patel, board certified in obstetrics and gynecology, has joined Capital Health OB/GYN, a growing women's health practice that is part of Capital Health Medical . . .
Posted on 5/29/20
CipherHealth Named "Best Overall Patient Engagement Company" in 2020 MedTech Breakthrough Awards
CipherHealth, a proven leader in healthcare technology solutions for patient engagement and communication, today announced thatMedTech Breakthrough, an independent market intelligence organization that recognizes the top . . .
Posted on 5/27/20
Ambra Health Named Best Healthcare Technology Solution at 2020 SIIA CODiE Awards
With healthcare facilities increasingly turning to technology to power telehealth options, Ambra Health, makers of the leading cloud-based, medical image management suite, today announced the company . . .
Posted on 5/27/20
Hoth Therapeutics Closes Public Offering of Common Stock
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, announced today the closing of its previously announced underwritten public offering of 1,818,182 shares of its common stock, at . . .
Posted on 5/27/20
Deerfield Commits Up to $130 Million to Commercialize Drug Discovery at University of Michigan
ANN ARBOR, Mich. & NEW YORK--(BUSINESS WIRE)--A new partnership between the University of Michigan (U-M) and health care investment firm Deerfield Management Co. will create a . . .
Posted on 5/27/20
At Last, Merck Is Diving Into Coronavirus Vaccine and Antiviral Development
Another giant pharmaceutical company has thrown its hat into the SARS-CoV-2 vaccine development ring: Merck (NYSE:MRK), which has up until now been quiet on the pandemic . . .
Posted on 5/27/20
Is Axsome Therapeutics a Buy?
Success stories such as Axsome Therapeutics (NASDAQ:AXSM) are rare in the world of investing, but the company is proof that such opportunities do exist, and that . . .
Posted on 5/27/20
Regeneron Prices Secondary Offering of its Common Stock Held by Sanofi
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the pricing of the underwritten public secondary offering of 11,831,496 shares of its common stock held by Sanofi at . . .
Posted on 5/26/20
States with the Best Health Infrastructure for Coronavirus – WalletHub Study
COVID-19 has exposed weaknesses in the country’s healthcare system, from supplies to staffing to bed counts, but issues have been far from uniform across the U.S. . . .
New York
